Sarcoid-like reactions: a potential pitfall in oncologic imaging by Gebrekidan, Selamawit et al.
IMAGE OF THE MONTH
Sarcoid-like reactions: a potential pitfall in oncologic imaging
Selamawit Gebrekidan1 & Tina Schaller2 & Andreas Rank3 & Malte Kircher1 & Constantin Lapa1
Received: 22 April 2020 /Accepted: 13 July 2020
# The Author(s) 2020
A 44-year-old female with the primary diagnosis of classic
(nodular sclerosing) Hodgkin’s lymphoma (HL) was referred
for further diagnostic work-up.Whole-body positron emission
tomography/computed tomography (PET/CT) using 18F-
fluorodeoxyglucose (FDG) revealed multiple nodal HL man-
ifestations in the right external iliac and inguinal regions (Ann
Arbor II, red arrow).
Subsequently, the patient underwent chemotherapy with
two cycles of escalated BEACOPP, resulting in CT-based
partial response. Therefore, two cycles of ABVD and local
radiotherapy were added in curative intent.
While the formerly affected lymph nodes showed a com-
plete metabolic response at end-of-treatment PET/CT
(Deauville score: 2), newly enlarged mediastinal and bilateral
hilar lymph nodes with increased FDG-uptake as well as sev-
eral hypermetabolic bone lesions were detected (red stars, in-
sert B–D). A biopsy from a tracer-avid lesion in the anterior
superior iliac spine was obtained. Histology revealed only
non-caseating epitheloid cells and giant cells (black stars, in-
sert A) adjacent to blood vessels (black arrows, insert A),
indicative of sarcoidosis. Since bronchoalveolar lavage and
endobronchial ultrasound-guided transbronchial needle aspi-
ration did not reveal malignant cells either, no further therapy
was initiated. Due to the absence of clinical symptoms, a
sarcoid-like reaction was favored over actual sarcoidosis as
the possible diagnosis.
After 3 months, follow-up PET/CT showed almost com-
plete remission of the lymphadenopathy and bone lesions
(Deauville score: 2) supporting the hypothesis of a tumor-
related sarcoid-like reaction.
Sarcoid-like reactions are observed in up to 13.8% of HL
patients and should be taken into account as a differential
diagnosis for hilar and/or mediastinal lymphadenopathy in
patients with a history of malignancy [1–3]. In case of uncer-
tainty, a tissue biopsy is recommended to differentiate be-
tween the two entities and to avoid misdiagnosis.
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